Related Experiment Video
Updated: Aug 26, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
[Effects of 3-substituted aryl oxindole(PH II-7) on cell cycle of tumor cells]
Yao-hong Tan1, Chun-zheng Yang, Jing Qi
1State Key Laboratory of Experimental Hematology, Institute of Hematology, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin 300020, China.
Aim:
To study the antitumor mechanism of 3-substituted aryl oxindole (PH II-7) and determine its effects on cell cycle distribution of tumor cells.
Methods:
The cell cycle distributions were determined with FACS. The cell cycle regulation-related proteins of K562 lysates were analyzed with Western Blot. The inhibition of PH II-7 on DNA synthesis of tumor cells were estimated though 3H-thymidine incorporation and the tyrosine kinase activity of EGFR of A431 lysates was measured with ELISA.
Results:
PH II-7 effected cell cycle distribution of several tumor cells, including multidrug resistant tumor cell lines, and accumulation of cells in the G0-G1 stages was observed. The cell cycle regulation-related proteins CDK2, Rb and c-myc were inhibited by PH II-7 in a dose dependent manner, whereas the expression of CyclinE was increased after exposure to PH II-7. Furthermore, PH II-7 2.0 mg.L-1 was shown to inhibit the incorporation of 3H-thymidine into DNA, and 21.89%-41.29% of the PTK activity of EGFR in A431 lysates was inhibited by PH II-7 2-8 mg.L-1 in a dose-dependant manner.
Conclusion:
PH II-7, a new anti-tumor agent, blocks the transition of cell cycle of tumor cells from G1 to S phase by inhibition CDK2.
Insights
The novel anti-tumor agent PH II-7 halts tumor cell cycle progression at the G1 to S phase transition by inhibiting CDK2. This mechanism affects DNA synthesis and EGFR tyrosine kinase activity.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Oxindole derivatives are investigated for their anti-cancer properties.
- Understanding the cell cycle regulation in tumor cells is crucial for developing targeted therapies.
Purpose of the Study:
- To elucidate the anti-tumor mechanism of 3-substituted aryl oxindole (PH II-7).
- To determine the effects of PH II-7 on tumor cell cycle distribution.
Main Methods:
- Flow cytometry (FACS) for cell cycle analysis.
- Western Blotting to assess cell cycle regulatory proteins.
- 3H-thymidine incorporation and ELISA to measure DNA synthesis and EGFR activity.
Main Results:
- PH II-7 induced G0-G1 phase arrest in various tumor cells, including multidrug-resistant lines.
- Dose-dependent inhibition of CDK2, Rb, and c-myc, with increased Cyclin E expression.
- Inhibition of DNA synthesis and epidermal growth factor receptor (EGFR) tyrosine kinase activity.
Conclusions:
- PH II-7 acts as an anti-tumor agent by blocking G1 to S phase transition.
- CDK2 inhibition is a key mechanism by which PH II-7 exerts its anti-tumor effects.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Positive Regulator Molecules
